Clinical Trials on Metastatic Uveal Melanoma
Total 12803 results
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Sheba Medical CenterUnknownMetastatic MelanomaIsrael
-
Myrexis Inc.Completed
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
Carman GiacomantonioNova Scotia Health AuthorityWithdrawnCutaneous Metastatic Melanoma
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Wilson MillerActive, not recruitingMetastatic Malignant MelanomaCanada
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
National Cancer Institute (NCI)TerminatedMetastatic Cancer | Metastatic Melanoma | Metastatic Renal CancerUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Cancer | Metastatic Melanoma | Metastatic Renal CancerUnited States
-
California Cancer Assocaties for Research & ExcellenceUnknownMetastatic Melanoma | Malignant Melanoma of Skin Stage IIIUnited States
-
Qilu Hospital of Shandong UniversityNot yet recruitingLocally Advanced or Metastatic Acral Malignant MelanomaChina
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Philogen S.p.A.Active, not recruiting
-
Shields, Shields and AssociatesUnknownUveal Melanoma | Radiation Retinopathy | Radiation MaculopathyUnited States
-
DNA TherapeuticsCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Metastatic Cutaneous Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Mucosal MelanomaUnited States
-
BiocadActive, not recruitingUnresectable or Metastatic MelanomaRussian Federation
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Bristol-Myers SquibbCompletedAdvanced or Metastatic MelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic (Stage IV) MelanomaFrance
-
Vastra Gotaland RegionWithdrawnMelanoma | Surgery | Metastatic Melanoma | Melanoma Stage IVSweden
-
Delcath Systems Inc.National Cancer Institute (NCI)CompletedMetastatic Cancer | Intraocular Melanoma | Melanoma (Skin)United States
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
St. Louis UniversityCompletedMelanoma | Metastatic Melanoma | Stage IV Melanoma | Unresectable Malignant Neoplasm | Stage III MelanomaUnited States
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Case Comprehensive Cancer CenterCompletedMetastatic or Unresectable MelanomaUnited States
-
Institut Paoli-CalmettesSociété Francophone d'Onco-GériatrieUnknownAdvanced or Metastatic NSCLC | Advanced or Metastatic MelanomaFrance
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
Samsung Medical CenterCompletedMetastatic Melanoma With KIT AberrationKorea, Republic of
-
Mayo ClinicNot yet recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the LungUnited States
-
Kari KendraRecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
University Hospital, BrestRecruitingPET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy (IMMUNOPET2)Metastatic MelanomaFrance
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Jonsson Comprehensive Cancer CenterPfizer; Schering-PloughCompletedTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaMetastatic MelanomaUnited States
-
International Group of Endovascular OncologyUnknownMetastatic MelanomaItaly
-
Infinity Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
Zai Lab (Shanghai) Co., Ltd.TerminatedUnresectable, Recurrent or Metastatic Melanoma | Untreated Mucosal or Acral Lentiginous MelanomaChina